Neutrophil gelatinase-associated lipocalin in kidney transplantation: A review

Transplantation Reviews

Volumn 29, Issue 3, 2015, Pages 139-144

  Ramirez Sandoval, Juan C ^a   Herrington, William ^b   Morales Buenrostro, Luis E ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN;

ACUTE KIDNEY FAILURE; CAUSAL ATTRIBUTION; DELAYED GRAFT FUNCTION; EARLY DIAGNOSIS; HUMAN; KIDNEY TRANSPLANTATION; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; RENAL GRAFT DYSFUNCTION; REVIEW; ADVERSE EFFECTS; ALLOTRANSPLANTATION; BLOOD; GRAFT REJECTION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGIC MONITORING; PREDICTIVE VALUE; PROCEDURES; TIME FACTOR; URINE;

ACUTE-PHASE PROTEINS; BIOMARKERS; DELAYED GRAFT FUNCTION; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; LIPOCALINS; MONITORING, PHYSIOLOGIC; PREDICTIVE VALUE OF TESTS; PROTO-ONCOGENE PROTEINS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84952023205     PISSN: 0955470X     EISSN: 15579816     Source Type: Journal    
DOI: 10.1016/j.trre.2015.04.004     Document Type: Review

References (64)

1. Suthanthiran M., Strom T.B. Renal transplantation. N Engl J Med 1994, 331:365-376.
2. Pussell B.A., Bendorf A., Kerridge I.H. Access to the kidney transplant waiting list: a time for reflection. Intern Med J 2012, 42:360-363.
3. Meier-Kriesche H.U., Schold J.D., Srinivas T.R., Kaplan B. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004, 4:378-383.
4. Meier-Kriesche H.U., Schold J.D., Kaplan B. Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies?. Am J Transplant 2004, 4:1289-1295.
5. Serón D., Burgos D., Alonso A. Histology and proteinuria after renal transplantation. Transplant Rev (Orlando) 2012, 26:20-26.
6. Kim S.C., Page E.K., Knechtle S.J. Urine proteomics in kidney transplantation. Transplant Rev (Orlando) 2014, 28:15-20.
7. Kjeldsen L., Johnsen A.H., Sengeløv H., Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 1993, 268:10425-10432.
8. Flo T.H., Smith K.D., Sato S., et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 2004, 432:917-921.
9. Langelueddecke C., Roussa E., Fenton R.A., Wolff N.A., Lee W.K., Thévenod F. Lipocalin-2 (24p3/neutrophil gelatinase-associated lipocalin (NGAL)) receptor is expressed in distal nephron and mediates protein endocytosis. J Biol Chem 2012, 287:159-169.
10. Yang J., Goetz D., Li J.Y., et al. An iron delivery pathway mediated by a lipocalin. Mol Cell 2002, 10:1045-1056.
11. Goetz D.H., Holmes M.A., Borregaard N., Bluhm M.E., Raymond K.N., Strong R.K. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell 2002, 10:1033-1043.
12. Paragas N., Qiu A., Hollmen M., Nickolas T.L., Devarajan P., Barasch J. NGAL - Siderocalin in kidney disease. Biochim Biophys Acta 1823, 2012:1451-1458.
13. Mårtensson J., Xu S., Bell M., Martling C.R., Venge P. Immunoassays distinguishing between HNL/NGAL released in urine from kidney epithelial cells and neutrophils. Clin Chim Acta 2012, 413:1661-1667.
14. Kashiwagi E., Tonomura Y., Kondo C., et al. Involvement of neutrophil gelatinase-associated lipocalin and osteopontin in renal tubular regeneration and interstitial fibrosis after cisplatin-induced renal failure. Exp Toxicol Pathol 2014, 66:301-311.
15. Schmidt-Ott K.M., Mori K., Li J.Y., et al. Dual action of neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 2007, 18:407-413.
16. Kuwabara T., Mori K., Mukoyama M., et al. Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons. Kidney Int 2009, 75:285-294.
17. Ramirez-Sandoval J.C., Barrera-Chimal J., Simancas P.E., Correa-Rotter R., Bobadilla N.A., Morales-Buenrostro L.E. Tubular urinary biomarkers do not identify aetiology of acute kidney injury in kidney transplant recipients. Nephrology (Carlton) 2014, 19:352-358.
18. Lebkowska U., Malyszko J., Lebkowska A., et al. Neutrophil gelatinase-associated lipocalin and cystatin C could predict renal outcome in patients undergoing kidney allograft transplantation: a prospective study. Transplant Proc 2009, 41:154-157.
19. Singer E., Markó L., Paragas N., et al. Neutrophil gelatinase-associated lipocalin: pathophysiology and clinical applications. Acta Physiol (Oxf) 2013, 207:663-672.
20. Devarajan P. Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury. Biomark Med 2010, 4:265-280.
21. Barrera-Chimal J., Bobadilla N.A. Are recently reported biomarkers helpful for early and accurate diagnosis of acute kidney injury?. Biomarkers 2012, 17:385-393.
22. Kaplan B., Schold J., Meier-Kriesche H.U. Poor predictive value of serum creatinine for renal allograft loss. Am J Transplant 2003, 3:1560-1565.
23. Hollmen M.E., Kyllönen L.E., Merenmies J., Salmela K.T. Serum neutrophil gelatinase-associated lipocalin and recovery of kidney graft function after transplantation. BMC Nephrol 2014 Jul 28, 15:123. 10.1186/1471-2369-15-123.
24. Mallon D.H., Summers D.M., Bradley J.A., Pettigrew G.J. Defining delayed graft function after renal transplantation: simplest is best. Transplantation 2013, 96:885-889.
25. Irish W.D., McCollum D.A., Tesi R.J., et al. Nomogram for predicting the likelihood of delayed graft function in adult cadaveric renal transplant recipients. J Am Soc Nephrol 2003, 14:2967-2974.
26. Troppmann C., Gillingham K.J., Benedetti E., et al. Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. The multivariate analysis. Transplantation 1995, 59:962-968. [Sharif et al, 2013].
27. Sharif A., Borrows R. Delayed graft function after kidney transplantation: the clinical perspective. Am J Kidney Dis 2013, 62:150-158.
28. Yarlagadda S.G., Coca S.G., Formica R.N., Poggio E.D., Parikh C.R. Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis. Nephrol Dial Transplant 2009, 24:1039-1047.
29. Tapiawala S.N., Tinckam K.J., Cardella C.J., et al. Delayed graft function and the risk for death with a functioning graft. J Am Soc Nephrol 2010, 21:153-161.
30. Siedlecki A., Irish W., Brennan D.C. Delayed graft function in the kidney transplant. Am J Transplant 2011, 11:2279-2296.
31. Mishra J., Ma Q., Kelly C., et al. Kidney NGAL is a novel early marker of acute injury following transplantation. Pediatr Nephrol 2006, 21:856-863. [Haase et al, 2009].
32. Haase-Fielitz A., Haase M., Devarajan P. Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury: a critical evaluation of current status. Ann Clin Biochem 2014, 51:335-351.
33. Pajek J., Škoberne A., Šosterič K., et al. Non-inferiority of creatinine excretion rate to urinary L-FABP and NGAL as predictors of early renal allograft function. BMC Nephrol 2014 Jul 16, 15:117. 10.1186/1471-2369-15-117.
34. Fonseca I., Oliveira J.C., Almeida M., et al. Neutrophil gelatinase-associated lipocalin in kidney transplantation is an early marker of graft dysfunction and is associated with one-year renal function. J Transplant 2013, 2013:650123. Epub 2013 Oct 31. 10.1155/2013/650123.
35. Buemi A., Musuamba F., Frederic S., et al. Is plasma and urine neutrophil gelatinase-associated lipocalin (NGAL) determination in donors and recipients predictive of renal function after kidney transplantation?. Clin Biochem 2014, 47:68-72.
36. Choi H.M., Park K.T., Lee J.W., et al. Urine neutrophil gelatinase-associated lipocalin predicts graft outcome up to 1year after kidney transplantation. Transplant Proc 2013, 45:122-128.
37. Hall I.E., Doshi M.D., Poggio E.D., Parikh C.R. A comparison of alternative serum biomarkers with creatinine for predicting allograft function after kidney transplantation. Transplantation 2011, 91:48-56.
38. Nakamura M., Seki G., Iwadoh K., et al. Acute kidney injury as defined by the RIFLE criteria is a risk factor for kidney transplant graft failure. Clin Transplant 2012, 26:520-528.
39. Mehrotra A., Rose C., Pannu N., Gill J., Tonelli M., Gill J.S. Incidence and consequences of acute kidney injury in kidney transplant recipients. Am J Kidney Dis 2012, 59:558-565.
40. Ramirez-Sandoval J.C., Barrera-Chimal J., Simancas P.E., et al. Urinary neutrophil gelatinase-associated lipocalin predicts graft loss after acute kidney injury in kidney transplant. Biomarkers 2014, 19:63-69.
41. Haase M., Bellomo R., Devarajan P., Schlattmann P., Haase-Fielitz A. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009, 54:1012-1024. NGAL Meta-analysis Investigator Group.
42. Kaufeld J.K., Gwinner W., Scheffner I., Haller H.G., Schiffer M. Urinary NGAL ratio is not a sensitive biomarker for monitoring acute tubular injury in kidney transplant patients: NGAL and ATI in renal transplant patients. J Transplant 2012, 2012:563404. Epub 2012 Dec 27. 10.1155/2012/563404.
43. Field M., Lowe D., Cobbold M., et al. The use of NGAL and IP-10 in the prediction of early acute rejection in highly sensitized patients following HLA-incompatible renal transplantation. Transpl Int 2014, 27:362-370.
44. Heyne N., Kemmner S., Schneider C., Nadalin S., Königsrainer A., Häring H.U. Urinary neutrophil gelatinase-associated lipocalin accurately detects acute allograft rejection among other causes of acute kidney injury in renal allograft recipients. Transplantation 2012, 93:1252-1257.
45. Zhang R., Li M., Chouhan K.K., Simon E.E., Hamm L.L., Batuman V. Urine free light chains as a novel biomarker of acute kidney allograft injury. Clin Transplant 2013, 27:953-960.
46. Field M., Dronavalli V., Mistry P., et al. Urinary biomarkers of acute kidney injury in deceased organ donors-kidney injury molecule-1 as an adjunct to predicting outcome. Clin Transplant 2014, 28:808-815.
47. Pianta T.J., Peake P.W., Pickering J.W., et al. Clusterin in kidney transplantation: novel biomarkers versus serum creatinine for early prediction of delayed graft function. Transplantation 2015, 99:171-179.
48. Rostami Z., Nikpoor M., Einollahi B. Urinary neutrophil gelatinase associated lipocalin (NGAL) for early diagnosis of acute kidney injury in renal transplant recipients. Nephrourol Mon 2013, 5:745-752.
49. Salamzadeh J., Sahraee Z., Nafar M., Parvin M. Delayed graft function (DGF) after living donor kidney transplantation: a study of possible explanatory factors. Ann Transplant 2012, 17:69-76.
50. Hollmen M.E., Kyllönen L.E., Inkinen K.A., Lalla M.L., Salmela K.T. Urine neutrophil gelatinase-associated lipocalin is a marker of graft recovery after kidney transplantation. Kidney Int 2011, 79:89-98.
51. Qurashi S., Ghamdi G., Jaradat M., et al. Urinary neutrophil gelatinase-associated lipocalin and the occurrence of delayed graft function after kidney transplant. Exp Clin Transplant 2014, 12:396-400.
52. Hollmen M.E., Kyllönen L.E., Inkinen K.A., Lalla M.L., Merenmies J., Salmela K.T. Deceased donor neutrophil gelatinase-associated lipocalin and delayed graft function after kidney transplantation: a prospective study. Crit Care 2011, 15:R121. 10.1186/cc10220.
53. Lee E.Y., Kim M.S., Park Y., Kim H.S. Serum neutrophil gelatinase-associated lipocalin and interleukin-18 as predictive biomarkers for delayed graft function after kidney transplantation. J Clin Lab Anal 2012, 26:295-301.
54. Rahimzadeh N., Otukesh H., Hoseini R., et al. Are serum and urine neutrophil gelatinase-associated lipocalin predictive of renal graft function in short term?. Pediatr Transplant 2012, 16:796-802.
55. Parikh C.R., Jani A., Mishra J., et al. Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant 2006, 6:1639-1645.
56. Kusaka M., Kuroyanagi Y., Mori T., et al. Serum neutrophil gelatinase-associated lipocalin as a predictor of organ recovery from delayed graft function after kidney transplantation from donors after cardiac death. Cell Transplant 2008, 17:129-134.
57. Bataille A., Abbas S., Semoun O., et al. Plasma neutrophil gelatinase-associated lipocalin in kidney transplantation and early renal function prediction. Transplantation 2011, 92:1024-1030.
58. Hall I.E., Yarlagadda S.G., Coca S.G., et al. IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation. J Am Soc Nephrol 2010, 21:189-197.
59. Yang J., Choi H.M., Seo M.Y., et al. Urine liver-type fatty acid-binding protein predicts graft outcome up to 2years after kidney transplantation. Transplant Proc 2014, 46:376-380.
60. Wasilewska A., Zoch-Zwierz W., Taranta-Janusz K., Michaluk-Skutnik J. Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of cyclosporine nephrotoxicity?. Pediatr Nephrol 2010, 25:889-897.
61. Tsuchimoto A., Shinke H., Uesugi M., et al. Urinary neutrophil gelatinase-associated lipocalin: a useful biomarker for tacrolimus-induced acute kidney injury in liver transplant patients. PLoS One 2014 Oct 20, 9(10):e110527. eCollection 2014. 10.1371/journal.pone.0110527.
62. Lucarelli G., Mancini V., Galleggiante V., et al. Emerging urinary markers of renal injury in obstructive nephropathy. Biomed Res Int 2014, 2014:303298. Epub 2014 Jul 2. 10.1155/2014/303298.
63. Ding H., He Y., Li K., et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy. Clin Immunol 2007, 123:227-234.
64. Rau S., Schönermarck U., Jäger G., et al. BK virus-associated nephropathy: neutrophil gelatinase-associated lipocalin as a new diagnostic tool?. Clin Transplant 2013, 27:E184-E191.